Chesnara Plc: Fourth acquisition in two years
12 November 2026
Sionna Therapeutics, Inc. (NASDAQ: SION), a key player in the biotechnology sector, has been making waves with its focus on innovative treatments for cystic fibrosis (CF)...
Keros Therapeutics, Inc. (NASDAQ: KROS) is making waves in the biotechnology sector with its promising pipeline and recent analyst ratings suggesting a substantial growth potential. With..
Stoke Therapeutics, Inc. (NASDAQ: STOK) is gaining attention in the biotechnology sector, not just for its innovative approach to treating severe genetic diseases but also for..
Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, has captured investor attention with its potential for significant upside, despite facing formidable challenges in its current..
Inventiva S.A. (IVA), listed as an American Depositary Share, has captured the attention of savvy investors in the biotechnology sector with a tantalizing potential upside of..
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a prominent player in the biotechnology sector, stands out for its innovative approach to cell programming and biosecurity. Despite facing..
Cel-Sci Corporation (NASDAQ: CVM) stands out in the biotechnology sector with an eye-catching potential upside of 823.91%, according to recent analyst ratings. This clinical-stage biotech firm,..
AMN Healthcare Services Inc (AMN), a prominent player in the healthcare sector, is navigating a challenging yet opportunity-laden landscape. Specializing in medical care facilities, AMN provides..
Butterfly Network, Inc. (NYSE: BFLY), a prominent player in the healthcare sector, is shaking up the medical devices industry with its innovative ultrasound imaging solutions. Known..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a clinical-stage pharmaceutical company, is drawing attention from investors due to its significant potential upside of 50.04% according to analyst ratings...
Gyre Therapeutics, Inc. (GYRE), a promising player in the biotechnology sector, is capturing the attention of investors with its significant potential upside of 130.18%. Headquartered in..
For investors with an eye on the biotechnology sector, Cullinan Therapeutics, Inc. (CGEM) presents a compelling opportunity. With a market capitalization of $690.6 million and a..
InMode Ltd. (NASDAQ: INMD) is capturing attention in the healthcare sector with its innovative approach to medical devices, specifically in the realm of minimally invasive aesthetic..
Avanos Medical, Inc. (NYSE: AVNS), a notable player in the medical devices sector, presents a compelling case for investors seeking opportunities within the healthcare industry. Headquartered..
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a prominent player in the biotechnology industry, is capturing investor attention with its promising pipeline and remarkable potential upside. With a..
MeiraGTx Holdings plc (NASDAQ: MGTX), a biotechnology company at the forefront of genetic medicine, is garnering significant attention from investors due to its innovative pipeline and..
Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, is at the forefront of developing biotherapeutics for cancer and autoimmune diseases. With a notable market cap of..
Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates a range of medical care facilities across the United States. With a..
Auna SA (AUNA), a healthcare service provider operating hospitals and clinics in Mexico, Peru, and Colombia, presents a compelling opportunity for investors seeking exposure to the..
InnovAge Holding Corp. (NASDAQ: INNV) presents a compelling narrative for investors in the healthcare sector, with its focus on providing comprehensive care services to seniors. Headquartered..
